BIOMAT Database Logo BIOMAT Database Logo

Cell substrates. Their use in the production of vaccines and other biologicals. Benefit-risk assessment. 1979

H B Dull

UI MeSH Term Description Entries
D007603 Jurisprudence The science or philosophy of law. Also, the application of the principles of law and justice to health and medicine. Litigation,Medical Jurisprudence,Constitutional Law,Court Decision,Law,Legal Aspects,Legal Obligations,Legal Status,State Interest,Aspect, Legal,Aspects, Legal,Constitutional Laws,Court Decisions,Decision, Court,Decisions, Court,Interest, State,Interests, State,Jurisprudence, Medical,Law, Constitutional,Laws,Laws, Constitutional,Legal Aspect,Legal Obligation,Litigations,Obligation, Legal,Obligations, Legal,State Interests,Status, Legal
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine

Related Publications

H B Dull
Cell substrates. Their use in the production of vaccines and other biologicals.
January 1979, Advances in experimental medicine and biology,
H B Dull
Cell substrates. Their use in the production of vaccines and other biologicals. Past achievements - future expectations.
January 1979, Advances in experimental medicine and biology,
H B Dull
Cell substrates for biologicals other than vaccines. Introductory remarks.
January 1979, Advances in experimental medicine and biology,
H B Dull
The cellular immortalization process: relevant issues for the generation of cell substrates for production of vaccines and other biologicals.
January 2001, Developments in biologicals,
H B Dull
Benefit-risk assessment of vaccines.
February 2024, Vaccine,
H B Dull
Tumorigenicity testing of various cell substrates for production of biologicals.
January 1989, Developments in biological standardization,
H B Dull
Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.
January 1987, World Health Organization technical report series,
H B Dull
Cell substrates for the production of viral vaccines.
November 2015, Vaccine,
H B Dull
Animal cell substrates for the production of biologicals: An introduction to WHO documents.
December 2014, Biologicals : journal of the International Association of Biological Standardization,
H B Dull
Major issues associated with the use of cell substrates for the production of vaccines.
January 2001, Developments in biologicals,
Copied contents to your clipboard!